Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
about
Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentMaking Better Chimeric Antigen Receptors for Adoptive T-cell TherapyEnhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.Emerging Opportunities and Challenges in Cancer Immunotherapy.Reversing T-cell Dysfunction and Exhaustion in Cancer.The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy.Displaying Tetra-Membrane Spanning Claudins on Enveloped Virus-Like Particles for Cancer Immunotherapy.Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.Informatics for cancer immunotherapy.mRNA vaccines - a new era in vaccinology.Towards personalized, tumour-specific, therapeutic vaccines for cancer.Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.Use of antigen-primed dendritic cells for inducing antitumor immune responses in vitro in patients with non-small cell lung cancer.Mechanisms regulating T-cell infiltration and activity in solid tumors.Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.Immune oncology, immune responsiveness and the theory of everything.A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
P2860
Q28073613-749DDC15-657D-4984-B370-8D18C1C5F5FCQ36830759-DB7BB69E-2403-4AA7-9050-9E849578EE15Q38672403-918DA7B4-D37C-4727-B7FC-0975A17CFE8AQ38809772-95213FA9-0591-48DE-9A59-7E491D561111Q38809776-EE0F4544-8618-4FA9-BCA4-072DFF610CBBQ41673084-07C3DC94-ECBA-4541-852D-1E7886C868C7Q45324916-34C4DF5C-EC5C-49D8-97C8-5C32E580EBBDQ46195000-CFBC66CA-894C-48E8-8C55-2BF794BFF5C0Q47290509-C9443696-959D-4EB5-8BFA-034F223AB95BQ47736893-152EB686-7B9C-4FA3-8EB8-C86F3D760144Q47789519-0B98B573-5736-4A30-889A-2ECAB844E6F3Q48193685-C282721D-2B5F-4FE9-A62A-FDD7C35C006FQ49334976-5D45C0C0-1876-4908-9BC3-AB247BCB4930Q50089395-4843D27B-C383-40D7-8EBE-772DDD51EF6FQ55085319-833B3523-2BD3-49F1-8DDF-2DE5B59644E7Q55487467-3C311DF2-0879-4FC4-B2DE-9EE7E7B9EBAFQ58795622-19CD65B7-DB89-4CD9-BBE5-056024962DB5
P2860
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
@en
type
label
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
@en
prefLabel
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.
@en
P2093
P1476
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
@en
P2093
Christoph Huber
Mustafa Diken
Sebastian Kreiter
Özlem Türeci
P304
P356
10.1158/1078-0432.CCR-15-1509
P407
P577
2016-04-01T00:00:00Z